Remdesivir is the first drug authorized by Europe to treat coronavirus.
“Today, the European Commission has granted a conditional marketing authorization for the drug remdesivir. We will spare no effort to obtain effective treatments or vaccines against the coronavirus, “said Health Commissioner Stella Kyriakides, quoted in a press release, after authorization was granted less than a month after the filing of Requirement.
Indeed, it is the first drug authorized on European soil in the treatment of the coronavirus epidemic since the beginning of its appearance. Initially developed for Ebola hemorrhagic fever, this antiviral is the first therapy to have demonstrated some efficacy in patients hospitalized for Covid-19 in a clinical trial of significant size, even if the effect is considered to be modest.
In its recommendation last week, the European Medicines Agency (EMA), indicated that a study carried out on more than 1,000 hospital patients with Covid-19 showed that those treated with remdesivir recovered on average four days faster than other patients.